University of Colorado Denver
Aurora, Colorado, 80045, United States
NCT Number: NCT03101371
Urinary Tract Infection (UTI) complications following catheter use in surgical patients remains high. Using an aseptic protocol has been shown to drastically reduce UTI incidence by 50%. Reducing UTIs will prevent extended hospital stays, readmission, and antibiotic use associated with this complication and improve cost-effectiveness of care. The investigators hypothesize that they can reduce the incidence of UTIs after catheter placement with the implementation of a Quality Improvement (QI) protocol to prevent excess exposure to the environment exposure of the catheter before, during and after insertion.
Looking for future studies?
Notify Me18 year–89 year
Female
Interventional
Phase 2
Aurora, Colorado, 80045, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The catheter will be treated with Povidone Iodine prior to insertion.
Other names: Aseptic protocol for catheter insertion using Povidone Iodine treated catheter
Catheter inserted right out of package.
Time frame: Within 14 +/- 2 days post-surgery
Participants were monitored for up to 14 days. This was assessed with a rapid urine analysis (UA) test. A urinary tract infection was defined as >10^5 bacterial colony forming units per ML on urine culture regardless of symptoms. This is the number of participants who had at least one CAUTI during the time of observation.
Time frame: Day 14 (+/- 2 days)
Participants were monitored for up to 2 weeks. This is the number of participants who received one method versus the other for catheter discontinuation.
Time frame: Day14 (+/- 2 days)
Participants were monitored at 2 weeks. This was assessed using a Likert scale questionnaire (1 = not at all satisfied, 10 = extremely satisfied). Average patient satisfaction with the catheter was assessed.
Time frame: 14 days (+/- 2 days) from surgery
Participants were monitored for up to 14 days. This is the number of participants who had a UTI in the hospital, extending their stay for more than seven days.
Time frame: Day 1 post op
Participants were monitored post surgery until time of discharge. This is the number of participants who had the closed drainage system disrupted during placement of catheter for back fill of the bladder during surgery.
Time frame: Day 14 (+/- 2 days)
Participants were monitored up to two weeks. This is the number of participants who had at least one readmission or emergency room visit during the time of observation.
Time frame: Day 14 (+/- 2 days)
Participants were monitored for up to 2 weeks. This is the number of participants that used any antibiotic during surgery and post-surgery.
University of Colorado, Denver
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02358993
Catheter-Related Infections, Female Urogenital Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT03178734
Catheter-Related Infections, Female Urogenital Diseases
Morristown, New Jersey, United States
View Trial DetailsNCT02486653
Catheter-Related Infections, Female Urogenital Diseases
Madison, Wisconsin, United States
View Trial DetailsNCT07627412
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Nanjing, Jiangsu, China
View Trial Details